RINVOQ 30 mg
prolonged-release tablets
registration number
57/3.1/0624
What RINVOQ 30 mg contains
Upadacitinib hemihydrate.
other ingredients
Microcrystalline cellulose, Hypromellose, Mannitol, Tartaric acid, Silica (colloidal anhydrous), Magnesium stearate.
Therapeutic classification
L04AA44.